Madrigal Pharmaceuticals (MDGL) Stock Chart & Stock Price History $300.16 -2.48 (-0.82%) Closing price 07/1/2025 04:00 PM EasternExtended Trading$299.00 -1.16 (-0.39%) As of 04:05 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock Madrigal Pharmaceuticals Stock Price Performance The Madrigal Pharmaceuticals (MDGL) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has increased 10.49%, with a year-to-date return of -2.73%. In the past month, the stock has increased 10.08%, reflecting recent market activity. As of the latest close, Madrigal Pharmaceuticals traded at $300.16 with a market cap of $6.66 billion and volume of 217,851 shares. Five years ago, the stock traded at $111.58, representing a 169.01% increase over that period. At the time, it had a market cap of $1.75 billion and a volume of 143,799 shares. Receive MDGL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Madrigal Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance-0.20%1 Month Performance+10.08%3 Month Performance-10.29%Year-To-Date Performance-2.73%1 Year Performance+10.49%5 Year Performance+169.01% MDGL Stock Chart for Wednesday, July, 2, 2025 MDGL Chart by TradingView Madrigal Pharmaceuticals Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/01/2025$302.64$300.16-0.82%$301.39$291.45217,851 shs$6.66 billion06/30/2025$300.75$302.64+0.63%$308.92$299.21271,306 shs$6.72 billion06/27/2025$299.51$300.75+0.41%$314.22$295.62540,458 shs$6.68 billion06/26/2025$277.64$299.51+7.88%$300.30$278.00472,461 shs$6.65 billion06/25/2025$284.98$277.64-2.58%$284.99$277.64171,064 shs$6.16 billion06/24/2025$282.99$284.98+0.70%$290.00$279.00298,118 shs$6.33 billion06/23/2025$285.73$282.99-0.96%$285.50$276.67300,077 shs$6.28 billion06/20/2025$282.72$285.73+1.06%$287.85$279.33374,766 shs$6.34 billion06/19/2025$282.72$282.72$287.27$275.00303,304 shs$6.28 billion06/18/2025$279.60$282.72+1.12%$287.27$275.00303,304 shs$6.28 billion Get the Latest News and Ratings for MDGL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Madrigal Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 06/17/2025$285.06$279.60-1.92%$284.20$277.50219,547 shs$6.21 billion06/16/2025$295.57$285.06-3.56%$295.97$284.24332,877 shs$6.33 billion06/13/2025$297.21$295.57-0.55%$297.78$289.04270,711 shs$6.56 billion06/12/2025$294.34$297.21+0.98%$303.45$288.19378,482 shs$6.60 billion06/11/2025$282.32$294.34+4.26%$300.94$280.42417,989 shs$6.54 billion06/10/2025$280.24$282.32+0.74%$287.56$281.02143,415 shs$6.27 billion06/09/2025$278.23$280.24+0.72%$284.83$275.96310,471 shs$6.22 billion06/06/2025$274.10$278.23+1.51%$283.07$275.00279,463 shs$6.18 billion06/05/2025$279.32$274.10-1.87%$279.39$271.95292,513 shs$6.09 billion06/04/2025$284.41$279.32-1.79%$288.29$279.04227,910 shs$6.20 billion06/03/2025$272.67$284.41+4.31%$285.14$268.69405,097 shs$6.31 billion06/02/2025$276.70$272.67-1.46%$281.08$270.03287,804 shs$6.05 billion Related Companies Biogen Stock Chart Incyte Stock Chart United Therapeutics Stock Chart Neurocrine Biosciences Stock Chart Exelixis Stock Chart BioMarin Pharmaceutical Stock Chart Exact Sciences Stock Chart Repligen Stock Chart Halozyme Therapeutics Stock Chart Ionis Pharmaceuticals Stock Chart Receive MDGL Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Madrigal Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:MDGL) was last updated on 7/2/2025 by MarketBeat.com Staff From Our Partners379 passengers walked away from thisElon Musk just wrote a $51 million check to back this material’s next phase… Because it’s not just saving l...True Market Insiders | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | SponsoredIsrael-Iran WAR Could Destroy Trump's PresidencyThe missiles are already flying. Israel and Iran are now in direct military conflict — and this couldn't ha...American Alternative | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredThe #1 AI Energy StockNearly $600 billion is projected to be spent on AI data centers this year. That's because the ones being bu...Weiss Ratings | SponsoredTrump set to Boost Social Security Checks by 400%?If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Madrigal Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Madrigal Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
